BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12973732)

  • 1. Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis.
    Howard BA; Wang MZ; Campa MJ; Corro C; Fitzgerald MC; Patz EF
    Proteomics; 2003 Sep; 3(9):1720-4. PubMed ID: 12973732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a 17-protein signature in the serum of lung cancer patients.
    Sreseli RT; Binder H; Kuhn M; Digel W; Veelken H; Sienel W; Passlick B; Schumacher M; Martens UM; Zimmermann S
    Oncol Rep; 2010 Jul; 24(1):263-70. PubMed ID: 20514471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined biomarker pattern improves the discrimination of lung cancer.
    Liu L; Liu J; Wang Y; Dai S; Wang X; Wu S; Wang J; Huang L; Xiao X; He D
    Biomarkers; 2011 Feb; 16(1):20-30. PubMed ID: 20964562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of Serum Peptides in Patients with Lung Squamous Cell Carcinoma by MALDI-TOF-MS and Analysis of Their Correlation with Chemotherapy Efficacy].
    Zhao G; Xu B; Li X; Tang C; Qin H; Wang H; Yang S; Wang W; Gao H; He K; Liu X
    Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):318-325. PubMed ID: 28532539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of protein markers in serum and bronchoalveolar lavage fluid from patients with lung cancer by surface-enhanced laser desorption ionization time of flight mass spectrometry].
    Zhou JH; Liu GN; Huang SM; Zhong XN; Su H; Zhou Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Apr; 34(4):274-7. PubMed ID: 21609611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
    Shevchenko VE; Arnotskaya NE; Zaridze DG
    Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry serum protein profiling.
    Lin XL; Yang SY; Du J; Tian YX; Bu LN; Huo SF; Wang FP; Nan YD
    Chin Med J (Engl); 2010 Jan; 123(1):34-9. PubMed ID: 20137572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
    Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
    Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of serum protein biomarkers by surface enhanced laser desorption/ionization in patients with adenocarcinoma of the lung.
    Jiang M; Gu G; Ni B; Wang W; Shi J; Liao P; Hu H
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):e7-12. PubMed ID: 23441957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.
    Yildiz PB; Shyr Y; Rahman JS; Wardwell NR; Zimmerman LJ; Shakhtour B; Gray WH; Chen S; Li M; Roder H; Liebler DC; Bigbee WL; Siegfried JM; Weissfeld JL; Gonzalez AL; Ninan M; Johnson DH; Carbone DP; Caprioli RM; Massion PP
    J Thorac Oncol; 2007 Oct; 2(10):893-901. PubMed ID: 17909350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of serum proteins in the patients of lung adenocarcinoma by the method of magnetic bead based sample fractionation and MALDI-TOF-MS].
    Liu D; Liu LX; Yuan Q; Li XL; Huang N; Yang XD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):498-500, 556. PubMed ID: 20629331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary study of MALDI-TOF mass spectrometry-based screening of patients with the NSCLC serum-specific peptides].
    An J; Tang C; Wang N; Liu Y; Guo W; Li X; Wang Z; He K; Liu X
    Zhongguo Fei Ai Za Zhi; 2013 May; 16(5):233-9. PubMed ID: 23676979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a serum protein pattern from NSCLC patients treated with Gefitinib.
    Garrisi VM; Bongarzone I; Mangia A; Cremona M; De Bortoli M; Vaghi E; Galetta D; Pastorino U; Quaranta M; Abbate I; Paradiso A
    Clin Biochem; 2011 Jul; 44(10-11):936-40. PubMed ID: 21539823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced transthyretin expression in sera of lung cancer.
    Liu L; Liu J; Dai S; Wang X; Wu S; Wang J; Huang L; Xiao X; He D
    Cancer Sci; 2007 Oct; 98(10):1617-24. PubMed ID: 17683510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
    Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
    Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
    Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
    Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and identification of Serum Amyloid A protein elevated in lung cancer serum.
    Dai S; Wang X; Liu L; Liu J; Wu S; Huang L; Xiao X; He D
    Sci China C Life Sci; 2007 Jun; 50(3):305-11. PubMed ID: 17609886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
    Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
    Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.